Schonfeld Strategic Advisors’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-196,800
| Closed | -$362K | – | 2332 |
|
|
2024
Q4 | $362K | Sell |
196,800
-86,800
| -31% | -$160K | ﹤0.01% | 1475 |
|
|
2024
Q3 | $981K | Sell |
283,600
-350,600
| -55% | -$1.21M | 0.01% | 1037 |
|
|
2024
Q2 | $1.86M | Sell |
634,200
-488,900
| -44% | -$1.43M | 0.01% | 827 |
|
|
2024
Q1 | $6.35M | Buy |
1,123,100
+784,500
| +232% | +$4.43M | 0.04% | 466 |
|
|
2023
Q4 | $1.45M | Sell |
338,600
-16,400
| -5% | -$70.4K | 0.01% | 843 |
|
|
2023
Q3 | $1.23M | Sell |
355,000
-1,300
| -0.4% | -$4.51K | 0.01% | 838 |
|
|
2023
Q2 | $1.66M | Buy |
356,300
+10,304
| +3% | +$47.9K | 0.01% | 805 |
|
|
2023
Q1 | $1.6M | Buy |
345,996
+62,196
| +22% | +$287K | 0.02% | 759 |
|
|
2022
Q4 | $2.29M | Buy |
283,800
+236,000
| +494% | +$1.91M | 0.02% | 770 |
|
|
2022
Q3 | $265K | Sell |
47,800
-17,500
| -27% | -$97K | ﹤0.01% | 2122 |
|
|
2022
Q2 | $340K | Buy |
+65,300
| New | +$340K | ﹤0.01% | 1513 |
|
|
2021
Q2 | – | Sell |
-71,614
| Closed | -$1.63M | – | 2233 |
|
|
2021
Q1 | $1.63M | Sell |
71,614
-65,613
| -48% | -$1.49M | 0.02% | 693 |
|
|
2020
Q4 | $2.98M | Buy |
137,227
+86,227
| +169% | +$1.87M | 0.04% | 490 |
|
|
2020
Q3 | $512K | Buy |
+51,000
| New | +$512K | 0.01% | 867 |
|